• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于病毒 cDNA 文库的疫苗接种诱导广泛的抗原覆盖,从而治愈已建立的肿瘤。

Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors.

机构信息

Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

出版信息

Nat Med. 2011 Jun 19;17(7):854-9. doi: 10.1038/nm.2390.

DOI:10.1038/nm.2390
PMID:21685898
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3918897/
Abstract

Effective cancer immunotherapy requires the release of a broad spectrum of tumor antigens in the context of potent immune activation. We show here that a cDNA library of normal tissue, expressed from a highly immunogenic viral platform, cures established tumors of the same histological type from which the cDNA library was derived. Immune escape occurred with suboptimal vaccination, but tumor cells that escaped the immune pressure were readily treated by second-line virus-based immunotherapy. This approach has several major advantages. Use of the cDNA library leads to presentation of a broad repertoire of (undefined) tumor-associated antigens, which reduces emergence of treatment-resistant variants and also permits rational, combined-modality approaches in the clinic. Finally, the viral vectors can be delivered systemically, without the need for tumor targeting, and are amenable to clinical-grade production. Therefore, virus-expressed cDNA libraries represent a novel paradigm for cancer treatment addressing many of the key issues that have undermined the efficacy of immuno- and virotherapy to date.

摘要

有效的癌症免疫疗法需要在有效的免疫激活背景下释放广泛的肿瘤抗原。我们在这里表明,正常组织的 cDNA 文库,从高度免疫原性的病毒平台表达,可以治愈与 cDNA 文库来源相同的组织学类型的已建立的肿瘤。在疫苗接种不充分的情况下会发生免疫逃逸,但逃避免疫压力的肿瘤细胞很容易通过二线基于病毒的免疫疗法进行治疗。这种方法有几个主要优点。使用 cDNA 文库会导致呈现广泛的(未定义的)肿瘤相关抗原,这减少了治疗耐药变体的出现,并且还允许在临床上进行合理的联合治疗模式。最后,病毒载体可以全身递送,而不需要肿瘤靶向,并且易于临床级生产。因此,病毒表达的 cDNA 文库代表了一种新的癌症治疗范例,解决了迄今为止削弱免疫治疗和病毒治疗疗效的许多关键问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab13/3918897/377fd23cffcc/nihms292957f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab13/3918897/a52f9a3a8aea/nihms292957f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab13/3918897/dafaadb3a684/nihms292957f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab13/3918897/76c7839e0d11/nihms292957f3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab13/3918897/9db32101456d/nihms292957f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab13/3918897/d7ceea8f4147/nihms292957f5a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab13/3918897/377fd23cffcc/nihms292957f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab13/3918897/a52f9a3a8aea/nihms292957f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab13/3918897/dafaadb3a684/nihms292957f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab13/3918897/76c7839e0d11/nihms292957f3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab13/3918897/9db32101456d/nihms292957f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab13/3918897/d7ceea8f4147/nihms292957f5a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab13/3918897/377fd23cffcc/nihms292957f6.jpg

相似文献

1
Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors.基于病毒 cDNA 文库的疫苗接种诱导广泛的抗原覆盖,从而治愈已建立的肿瘤。
Nat Med. 2011 Jun 19;17(7):854-9. doi: 10.1038/nm.2390.
2
A viral strategy to ambush tumors.病毒式策略伏击肿瘤。
Nat Med. 2011 Jul 7;17(7):784-5. doi: 10.1038/nm0711-784.
3
Functional cloning of recurrence-specific antigens identifies molecular targets to treat tumor relapse.功能克隆复发特异性抗原鉴定分子靶标治疗肿瘤复发。
Mol Ther. 2013 Aug;21(8):1507-16. doi: 10.1038/mt.2013.116. Epub 2013 Jun 11.
4
Highly potent mRNA based cancer vaccines represent an attractive platform for combination therapies supporting an improved therapeutic effect.高效信使 RNA 癌症疫苗是一种很有吸引力的联合治疗平台,可以提高治疗效果。
J Gene Med. 2012 Jun;14(6):428-39. doi: 10.1002/jgm.2605.
5
Using in silico transcriptomics to search for tumor-associated antigens for immunotherapy.利用计算机转录组学寻找免疫治疗的肿瘤相关抗原。
Vaccine. 2001 Mar 21;19(17-19):2607-14. doi: 10.1016/s0264-410x(00)00500-4.
6
Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.用编码与恒定链直接相连的肿瘤抗原的腺病毒载体进行疫苗接种可诱导有效的不依赖CD4(+) T细胞的CD8(+) T细胞介导的肿瘤控制。
Eur J Immunol. 2009 Oct;39(10):2725-36. doi: 10.1002/eji.200939543.
7
Immunogene therapy.免疫基因疗法。
Adv Exp Med Biol. 2012;746:151-65. doi: 10.1007/978-1-4614-3146-6_12.
8
In vivo effects of vaccination with six-transmembrane epithelial antigen of the prostate: a candidate antigen for treating prostate cancer.前列腺六次跨膜上皮抗原疫苗接种的体内效应:一种治疗前列腺癌的候选抗原。
Cancer Res. 2007 Feb 1;67(3):1344-51. doi: 10.1158/0008-5472.CAN-06-2996.
9
Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy.重组痘病毒用于前列腺癌免疫治疗的前景与局限性
Curr Opin Mol Ther. 1999 Aug;1(4):471-9.
10
Clinical development of MVA-based therapeutic cancer vaccines.基于痘苗病毒安卡拉株的治疗性癌症疫苗的临床开发。
Expert Rev Vaccines. 2008 Sep;7(7):889-93. doi: 10.1586/14760584.7.7.889.

引用本文的文献

1
Oncolytic virus therapy in hepatocellular carcinoma.肝细胞癌的溶瘤病毒疗法
Oncol Res. 2025 Jun 26;33(7):1593-1610. doi: 10.32604/or.2025.061857. eCollection 2025.
2
Virus Against Cancer: Paradigm-Shifting Biological Concepts.对抗癌症的病毒:范式转变的生物学概念
Curr Neurol Neurosci Rep. 2025 Jun 14;25(1):41. doi: 10.1007/s11910-025-01428-4.
3
Cancer Immunotherapy Using AIRE Conditioning of the Tumor Epitopeome.利用自身免疫调节因子(AIRE)对肿瘤表位组进行调节的癌症免疫疗法。

本文引用的文献

1
Cellular vaccine approaches.细胞疫苗方法。
Cancer J. 2010 Jul-Aug;16(4):304-10. doi: 10.1097/PPO.0b013e3181eb33d7.
2
Potentiating cancer immunotherapy using an oncolytic virus.利用溶瘤病毒增强癌症免疫疗法。
Mol Ther. 2010 Aug;18(8):1430-9. doi: 10.1038/mt.2010.98. Epub 2010 Jun 15.
3
A vesicular stomatitis virus-based hepatitis B virus vaccine vector provides protection against challenge in a single dose.基于水疱性口炎病毒的乙型肝炎病毒疫苗载体可提供单次剂量接种的保护作用。
Res Sq. 2024 Nov 15:rs.3.rs-5411393. doi: 10.21203/rs.3.rs-5411393/v1.
4
Expression of tumor antigens within an oncolytic virus enhances the anti-tumor T cell response.肿瘤抗原在溶瘤病毒中的表达增强了抗肿瘤 T 细胞应答。
Nat Commun. 2024 Jun 27;15(1):5442. doi: 10.1038/s41467-024-49286-x.
5
Chimerization of the Anti-Viral CD8 T Cell Response with A Broad Anti-Tumor T Cell Response Reverses Inhibition of Checkpoint Blockade Therapy by Oncolytic Virotherapy.将抗病毒CD8 T细胞反应与广泛的抗肿瘤T细胞反应进行嵌合,可逆转溶瘤病毒疗法对检查点阻断疗法的抑制作用。
Res Sq. 2023 Nov 20:rs.3.rs-3576281. doi: 10.21203/rs.3.rs-3576281/v1.
6
Parking CAR T Cells in Tumours: Oncolytic Viruses as Valets or Vandals?将嵌合抗原受体T细胞储存在肿瘤中:溶瘤病毒是代客泊车者还是破坏者?
Cancers (Basel). 2021 Mar 5;13(5):1106. doi: 10.3390/cancers13051106.
7
Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy.溶瘤病毒治疗诱导 CSDE1 新抗原生成限制了 VSV 的复制,但可以通过免疫疗法进行靶向治疗。
Nat Commun. 2021 Mar 26;12(1):1930. doi: 10.1038/s41467-021-22115-1.
8
Vesicular Stomatitis Virus Encoding a Destabilized Tumor Antigen Improves Activation of Anti-tumor T Cell Responses.编码不稳定肿瘤抗原的水疱性口炎病毒增强抗肿瘤 T 细胞反应的激活。
Mol Ther. 2020 Dec 2;28(12):2540-2552. doi: 10.1016/j.ymthe.2020.08.013. Epub 2020 Aug 25.
9
Measles Vaccines Designed for Enhanced CD8 T Cell Activation.用于增强 CD8 T 细胞活化的麻疹疫苗。
Viruses. 2020 Feb 21;12(2):242. doi: 10.3390/v12020242.
10
Harnessing cancer immunotherapy during the unexploited immediate perioperative period.利用未被充分利用的围手术期即时进行癌症免疫治疗。
Nat Rev Clin Oncol. 2020 May;17(5):313-326. doi: 10.1038/s41571-019-0319-9. Epub 2020 Feb 17.
J Virol. 2010 Aug;84(15):7513-22. doi: 10.1128/JVI.00200-10. Epub 2010 May 26.
4
Involvement of members of the cadherin superfamily in cancer.钙黏蛋白超家族成员在癌症中的作用。
Cold Spring Harb Perspect Biol. 2009 Dec;1(6):a003129. doi: 10.1101/cshperspect.a003129. Epub 2009 Sep 23.
5
Tumor vaccines in 2010: need for integration.2010 年的肿瘤疫苗:需要整合。
Cell Immunol. 2010;263(2):138-47. doi: 10.1016/j.cellimm.2010.03.019. Epub 2010 Apr 3.
6
Potent vesicular stomatitis virus-based avian influenza vaccines provide long-term sterilizing immunity against heterologous challenge.基于强感染力水泡性口炎病毒的禽流感疫苗可提供针对异源挑战的长期有效免疫性。
J Virol. 2010 May;84(9):4611-8. doi: 10.1128/JVI.02637-09. Epub 2010 Feb 24.
7
Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity.复制缺陷型淋巴细胞脉络丛脑膜炎病毒载体的构建及其诱导强烈的 CD8+ T 细胞免疫反应的研究。
Nat Med. 2010 Mar;16(3):339-45. doi: 10.1038/nm.2104. Epub 2010 Feb 7.
8
Protection against lethal vaccinia virus challenge by using an attenuated matrix protein mutant vesicular stomatitis virus vaccine vector expressing poxvirus antigens.利用表达痘病毒抗原的弱化基质蛋白突变型水疱性口炎病毒疫苗载体预防致死性牛痘病毒攻击。
J Virol. 2010 Apr;84(7):3552-61. doi: 10.1128/JVI.01572-09. Epub 2010 Jan 20.
9
Antitumor immunity can be uncoupled from autoimmunity following heat shock protein 70-mediated inflammatory killing of normal pancreas.在热休克蛋白70介导的正常胰腺炎性杀伤后,抗肿瘤免疫可与自身免疫解偶联。
Cancer Res. 2009 Oct 1;69(19):7767-74. doi: 10.1158/0008-5472.CAN-09-1597. Epub 2009 Sep 8.
10
Cell carriers for oncolytic viruses: Fed Ex for cancer therapy.肿瘤溶瘤病毒的细胞载体:癌症治疗的“联邦快递”。
Mol Ther. 2009 Oct;17(10):1667-76. doi: 10.1038/mt.2009.194. Epub 2009 Aug 18.